Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Rapport Therapeutics, Inc.(RAPP) | 7,135,233 | 7,135,233 | 0 | $216.48M | $223.26M | 55.68% | +$6.78M |
| Septerna, Inc.(SEPN) | 6,215,591 | 6,215,591 | 0 | $173.29M | $149.36M | 37.25% | -$23.93M |
| Maze Therapeutics, Inc.(MAZE) | 950,800 | 950,800 | 0 | $39.39M | $28.38M | 7.08% | -$11.01M |